Policy & Regulation
Aspect Biosystems Closes USD 20m Series A Financing to Advance Its Leading Platform for 3D Bioprinting of Human Tissue
13 January 2020 - - Canadian biotechnology platform company Aspect Biosystems a biotechnology company pioneering microfluidic 3D bioprinting of human tissues has closed a USD 20m series A financing round, the company said.

Radical Ventures, a venture capital firm investing in entrepreneurs developing and applying deep tech to solve global problems and transform massive industries, led the round with participation from existing and new investors, including Pangaea Ventures, Pallasite Ventures, and Rhino Ventures.

Aspect will use this capital to advance multiple tissue therapeutic programs, expand its technology platform capabilities, and grow its world-leading team.

Aspect's broadly applicable technology platform enables the creation of living human tissues with unprecedented control, flexibility, and precision.

In addition to Aspect's internal tissue therapeutic programs for regenerative medicine, the company works with its global partners to create high-value solutions that will transform medical research and clinical practice.

Aspect Biosystems is a privately held biotechnology platform company pioneering the microfluidic 3D bioprinting of human tissues.

The company's proprietary technology has the potential to shape every aspect of human health by enabling the creation of human tissues for medical research, therapeutic discovery, and regenerative medicine.

Aspect is focused on partnering with academic institutions and biopharma companies to facilitate high-value discovery and development.

The company is also advancing internal tissue therapeutic programmes for regenerative medicine, with an initial focus on metabolic diseases and musculoskeletal injuries and disorders.

Radical Ventures is a venture capital firm investing in bold entrepreneurs developing and applying artificial intelligence and other deep technologies to invent the future.

Based in Toronto, Radical Ventures launched a USD 350m fund in 2019 focused on series A investments.

Radical Ventures was created by the founders of leading artificial intelligence company Layer 6 (acquired by TD Bank Group), who also co-founded the Vector Institute for Artificial Intelligence.


Related Headlines